Feng Ye

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Randomized Controlled Trial

Positive Breast Cancer

Peripheral Blood

Top Venues

Cancer medicine

NPJ breast cancer

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Jikun Feng, Jiarong Yi, Xiazi Zouxu, Jianxia Li, Zhenchong Xiong, Xinjian Huang, Wenjing Zhong, Weiling Huang, Feng Ye, Xi Wang
Peripheral blood lymphocytes subtypes as new predictors for neoadjuvant therapy efficacy in breast cancer. Cancer medicine 11 (15) (2022)
Yutian Zou, Shaoquan Zheng, Xinhua Xie, Feng Ye, Xiaoqian Hu, Zhi Tian, Shu-Mei Yan, Lu Yang, Yanan Kong, Yuhui Tang, Wenwen Tian, Jindong Xie, Xinpei Deng, Yan Zeng, Zhe-Sheng Chen, Xiaoming Xie, Xiaoming Xie
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nature communications 13 (1) (2022)
Lei Bian, Ping Yu, Jiahuai Wen, Na Li, Wanwei Huang, Xiaoming Xie, Feng Ye
Survival benefit of platinum-based regimen in early stage triple negative breast cancer: A meta-analysis of randomized controlled trials. NPJ breast cancer 7 (1) (2021)
Ping Yu, Peng Liu, Yutian Zou, Xinhua Xie, Xiaoming Xie, Na Li, Xiaoming Xie, Feng Ye
Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study. Cancer medicine 9 (15) (2020)
Feng Ye, Yubo Liu, Ping Yu, Na Li, Yan Wang, Xiaoming Xie, Jun Tang
Intraoperative ipsilateral subclavian port catheter implantation in resectable breast cancer patients: A novel, safe, and convenient clinical practice. Cancer medicine 9 (23) (2020)